Compare
2 stocks, side by sideRelative performance · rebased to 100
BBIOGMAB
Pair ratio · BBIO ÷ GMABRelative value, rich or cheap vs their own history
The price ratio BBIO ÷ GMAB with its 1Y mean and ±1σ / ±2σ bands; the z-score is how far the ratio sits from its average. A stretched reading flags one stock as rich vs the other relative to their history, but mean-reversion isn't guaranteed (a durable re-rating from better growth or margins can keep the ratio elevated). Research tooling, not advice.
| BBIOBridgeBio Pharma, Inc. | GMABGenmab A/S | |
|---|---|---|
| Smart Score | 3/10 | 9/10 |
| Price | $69.69 | $26.14 |
| 1 month | +2.9% | -2.8% |
| 1 year | +57% | +26% |
| 5 year | +11% | -40% |
| P/E (TTM) | -18.9 | 19.5 |
| P/E vs sector | - | -38% |
| Market cap | $13.6B | $16.0B |
| Sector | Healthcare | Healthcare |
Risk / Return · past yearAnnualized return vs volatility, up-and-left is more reward for less risk.
Correlation · do they move together?Pairwise daily-return correlation over the past year, high = one bet, low = diversifying.